User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 13 results.
    • Journal article
    Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning
    Dreger, P. Brand, R. Hansz, J. Milligan, D. Corradini, P. Finke, J. Deliliers, G. Lambertenghi Martino, R. Russell, N. van Biezen, A. Michallet, M. Niederwieser, D. Greinix, H. Ferrant, Augustin[UCL] Vitek, A. Vindelöv, L. Remes, K. Milpied, N. Kröger, N. Hertenstein, B. Trümper, L. Beelen, D. Derigs, G. Casper, J. Stilgenbauer, S. Bunjes, D. Corradini, P. Majolino, I. Willemze, R. Morgenstern, G. Aschan, J. Öberg, G. Esteve, J. Caballero, D. Iriondo, A. (2003) Leukemia — Vol. 17, no. 5, p. 841-848 (2003)
    • Speech
    Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.
    deWitte, TM Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Anak, O Hagemeijer, Anne[UCL] Selleslag, D. Delforge, Michel[UCL] Belhabi, A Schouten, H Gratwohl, A. Aul, C Aivado, M Amadori, S. Muus, P. Tigaud, I. Jotterand-Bellomo, M Willemze, R. (1999) —
    • Journal article
    Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
    de Witte, T. Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Archimbaud, E. Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Boogaerts, M. Zittoun, R Gratwohl, A. Zwierzina, H Hagemeijer, Anne[UCL] Willemze, R. (2001) Blood — Vol. 98, no. 8, p. 2326-2331 (2001)
    • Journal article
    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
    • Journal article
    Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
    Oosterveld, M Ferrant, Augustin[UCL] Muus, P. Suciu, Stefan[UCL] Koller, C Verhoef, G. Labar, B. Wijermans, P Aul, C Fiere, D. Selleslag, D. Willemze, R. Gratwohl, A. Mandelli, F. Cortes, J de Witte, T. Estey, E (2002) Leukemia — Vol. 16, no. 9, p. 1615-1621 (2002)
    • Speech
    Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups
    de Witte, T. Hagemeijer, Anne Suciu, Stefan[UCL] Belhabri, A Delforge, Michel Aul, C Aivado, M Selleslag, D. Schouten, H Ferrant, Augustin[UCL] Biersack, H Amadori, S. Muus, P. Jehn, U. Beeldens, F. Jansen, J Hellstrom-Lindberg, P Ossenkoppele, G Gratwohl, A. Marie, JP Willemze, R. (2006) 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group — Hamburg (Germany)
    • Journal article
    Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial
    Jehn, U. Suciu, Stefan[UCL] Thomas, X. Lefrere, F. Muus, P. Berneman, Z. Marie, J-P Adamo, F. Fillet, G. Nobile, F. Ricciuti, F. Leone, G. Rizzoli, V. Montanaro, M. Beeldens, F. Fazi, P. Mandelli, F. Willemze, R. de Witte, T. Amadori, S. (2006) Leukemia — Vol. 20, no. 10, p. 1723-1730 (2006)
    • Journal article
    Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
    Suciu, Stefan[UCL] Mandelli, F. de Witte, T. Zittoun, R Gallo, E Labar, B. De Rosa, G Belhabri, A Giustolisi, R Delarue, R. Liso, V Mirto, S Leone, G. Bourhis, JH Fioritoni, G Jehn, U. Amadori, S. Fazi, P. Hagemeijer, Anne[UCL] Willemze, R. (2003) Blood — Vol. 102, no. 4, p. 1232-1240 (2003)
    • Journal article
    Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: A retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
    Aoudjhane, M. Labopin, M. Gorin, N.C. Shimoni, A. Ruutu, T. Kolb, H.-J. Frassoni, F. Boiron, J.M. Yin, J.L. Finke, J. Shouten, H. Blaise, D. Falda, M. Fauser, A.A. Esteve, J. Polge, E. Slavin, S. Niederwieser, D. Nagler, A. Rocha, Vanderson Galiene, P. Petrini, M. Schlimok, G. Buzyn, A. Ovali, E. Gratwohl, A. Willemze, R. Bunjes, D. Goldman, J.M. Jacobsen, N. Gluckman, E. Schanz, U. Boogaerts, M.A. Ljungman, P. Montserrat, E. Bron, D. Potter, M. Bacigalupo, A. Powles, R. Rio, B. Kanz, L. Goldstone, A.H. Remes, K. Greinix, H.T. Davies, J.M. Blaise, D. Falda, M. Mandelli, F. Cahn, J.Y. Ferrant, Augustin[UCL] Brinch, L. Fernández-Ranada, J.M. Torres Gomez, A. Verdonck, L.F. Baccarani, M. Iriondo, A. Franklin, I. Rizzoli, V. Cornelissen, J.J. Van den Berg, H. Cordonnier, C. Harousseau, J.L. Barnard, D.L. Littlewood, T. Horst, H.A. McCann, S. Slavin, S. Schaefer, U.W. Sierra, J. Chapuis, B. Leblond, V. Guilhot, F. Lambertenghi Deliliers, G. Simonsson, B. Reiffers, J. Sotto, J.J. Gastl, G. Bay, J.O. Jackson, G.L. García-Conde, J. Lenhoff, S. Alessandrino, E.P. Majolino, I. Izzi, T. Brune, M. Pimentel, P. Siegert, W. Morra, E. Hertenstein, B. Hoelzer, D. Coser, P. Abecasis, M. Labar, B. Burnett, A.K. Bosi, A. Leone, G. Linkesch, W. Schwerdtfeger, R. Lauria, F. (2005) Leukemia — Vol. 19, no. 12, p. 2304-2312 (2005)
    • Journal article
    The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
    Keating, S Suciu, Stefan[UCL] de Witte, T. Zittoun, R Mandelli, F. Belhabri, A Amadori, S. Fibbe, W Gallo, E Fillet, G. Varet, B. Meloni, G Hagemeijer, Anne[UCL] Fazi, P. Solbu, G Willemze, R. (2003) Leukemia — Vol. 17, no. 1, p. 60-67 (2003)
    • Journal article
    The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA
    Keating, S de Witte, T. Suciu, Stefan[UCL] Willemze, R. Hayat, M. Labar, B. Resegotti, L Ferrini, PR Caronia, F Dardenne, M Solbu, G Petti, MC Vegna, ML Mandelli, F. Zittoun, RA (1998) British Journal of Haematology — Vol. 102, no. 5, p. 1344-1353 (1998)
    • Speech
    Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study
    Zittoun, R Suciu, Stefan[UCL] Solbu, G Watson, M. Muus, P. Mandelli, F. Stryckmans, P. Peetermans, M Thaler, J Willemze, R. (1995) —
    • Journal article
    Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA
    Keating, S de Witte, T. Suciu, Stefan[UCL] Mandelli, F. Damasio, E Willemze, R. Morra, E. Amadori, S. Dardenne, M Vegna, ML Zittoun, RA (1999) European Journal of Cancer — Vol. 35, no. 10, p. 1440-1447 (1999)